logo BDSP

Base documentaire


Votre avis nous intéresse

Le réseau BDSP met en oeuvre un projet d'innovation et d'amélioration de ses services, dans le souci constant de proposer des contenus de qualité adaptés aux besoins des utilisateurs.

Identifier de nouvelles sources de financements est la condition nécessaire pour assurer la poursuite et la pérennité de cet outil unique qu'est la BDSP, tout en le faisant évoluer.

Pour définir un nouveau modèle économique, nous avons besoin de votre avis : merci de répondre à notre enquête (temps estimé : 5 minutes).

Participer maintenant
Participer plus tard J'ai déjà participé

  1. What can be concluded from the Oxcheck and British family heart studies : commentary on cost effectiveness analyses.

    Article - En anglais

    Objectives-To provide a commentary on the economic evaluations of the Oxcheck and British family heart studies :

    • direct comparison of their relative effectiveness and cost effectiveness ;

    • comparisons with other interventions ;

    • and consideration of problems encountered.

    Design-Modelling from cost and effectiveness data to estimates of cost per life year gained.

    Subjects-Middle aged men and women

    Interventions-Screening for cardiovascular risk factors followed by appropriate lifestyle advice and drug intervention in general practice, and other primary coronary risk management strategies.

    Main outcome measures-Life years gained ; cost per life year gained.

    Results

    Depending on the assumed duration of risk reduction, the programme cost per discounted life year gained ranged from £34 800 for a 1 year duration to £1500 for 20 years for the British family heart study and from £29 300 to £900 for Oxcheck.

    These figures exclude broader net clinical and cost effects and longer term clinical and cost effects other than coronary mortality.

    Conclusions-Despite differences in underlying methods, the estimates in the two economic analyses of the studies can be directly compared.

    Neither study was large enough to provide precise estimates of the overall net cost.

    Modelling to cost per life year gained provides more readily interpretable measures.

    These estimates emphasise the importance of the relatively weak evidence on duration of effect.

    Only if the effect lasts at le...

    Mots-clés Pascal : Politique sanitaire, Soin santé primaire, Dépistage, Cardiopathie coronaire, Prévention, Education sanitaire, Facteur risque, Etude comparative, Coût, Efficacité, Résultat, Homme, Grande Bretagne, Royaume Uni, Europe, Appareil circulatoire pathologie, Etude Oxcheck

    Mots-clés Pascal anglais : Health policy, Primary health care, Medical screening, Coronary heart disease, Prevention, Health education, Risk factor, Comparative study, Costs, Efficiency, Result, Human, Great Britain, United Kingdom, Europe, Cardiovascular disease

    Logo du centre Notice produite par :
    Inist-CNRS - Institut de l'Information Scientifique et Technique

    Cote : 96-0279276

    Code Inist : 002B30A03B. Création : 199608.